Marisa Batti has had dermal filler injections since she turned 18. But after filler blocked a blood vessel, she wants other people to be aware of the risks.
Intravitreal brolucizumab and aflibercept in eyes with nAMD were each linked to a significant decrease in the ocular blood flow 30 minutes after injection.